Table 2.

Cell counts in recipient mice 6 weeks after bone marrow transplantation


Donor/recipient

Leukocytes in blood, ×109/L

BM, ×10-6

Ter119+ MNCs in BM, ×10-6

Spleen, ×10-7

Thymus, ×10-7
WT (CD45.2+)/WT (CD45.1+)   10.2 ± 2.0   20.3 ± 4.8   7.2 ± 0.6   11.1 ± 1.6   4.6 ± 1.0  
gp130flox/flox/TCre (CD45.2+)/WT (CD45.1+)   7.8 ± 1.8   26.7 ± 0.4   9.1 ± 1.7   9.8 ± 2.3   5.0 ± 0.5  
WT (CD45.1+)/WT (CD45.2+)   7.4 ± 1.4   30.3 ± 6.1   10.8 ± 1.7   10.3 ± 1.4   4.3 ± 0.3  
WT (CD45.1+)/gp130flox/flox/TCre (CD45.2+)
 
15.8 ± 4.1*
 
15.2 ± 1.2*
 
3.6 ± 1.0
 
23.0 ± 2.8*
 
1.7 ± 0.2*
 

Donor/recipient

Leukocytes in blood, ×109/L

BM, ×10-6

Ter119+ MNCs in BM, ×10-6

Spleen, ×10-7

Thymus, ×10-7
WT (CD45.2+)/WT (CD45.1+)   10.2 ± 2.0   20.3 ± 4.8   7.2 ± 0.6   11.1 ± 1.6   4.6 ± 1.0  
gp130flox/flox/TCre (CD45.2+)/WT (CD45.1+)   7.8 ± 1.8   26.7 ± 0.4   9.1 ± 1.7   9.8 ± 2.3   5.0 ± 0.5  
WT (CD45.1+)/WT (CD45.2+)   7.4 ± 1.4   30.3 ± 6.1   10.8 ± 1.7   10.3 ± 1.4   4.3 ± 0.3  
WT (CD45.1+)/gp130flox/flox/TCre (CD45.2+)
 
15.8 ± 4.1*
 
15.2 ± 1.2*
 
3.6 ± 1.0
 
23.0 ± 2.8*
 
1.7 ± 0.2*
 

Values are presented as mean ± SD; n = 8 mice.

BM indicates bone marrow; MNCs, mononuclear cells.

*

P < .05 compared with WT (CD45.1+) → WT (CD45.2+)

P < .01 compared with WT (CD45.1+) → WT (CD45.2+)

Close Modal

or Create an Account

Close Modal
Close Modal